VBI Vaccines
VBIV
#10526
Rank
A$2.65 M
Marketcap
A$0.09262
Share price
0.00%
Change (1 day)
-90.37%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$14.38. In 2022 the company made an earnings per share (EPS) of A-$18.72 a decrease over its 2021 EPS that were of A-$11.49.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$18.7262.96%
2021A-$11.4928.57%
2020A-$8.94-54.35%
2019A-$19.57-52.58%
2018A-$41.2810.23%
2017A-$37.4514.29%
2016A-$32.77-62.8%
2015A-$88.0890.68%
2014A-$46.19-7.95%
2013A-$50.19-57.97%
2012A-$119.42-78%
2011A-$542.893151.47%
2010A-$16.7023.87%
2009A-$13.48-18.48%
2008A-$16.5412.08%
2007A-$14.75-49.47%
2006A-$29.20
2005N/A-100%
2004A-$12.9811.94%
2003A-$11.60-81.89%
2002A-$64.03196.44%
2001A-$21.6084.33%
2000A-$11.72-65.37%
1999A-$33.84-29.45%
1998A-$47.9629.61%
1997A-$37.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.35-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.21-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.14-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA